An
Aminopyridines
/ pharmacology
Animals
Female
Lipoproteins, HDL
/ chemistry
Macrophages
/ drug effects
Mice
Positron Emission Tomography Computed Tomography
Pyrroles
/ pharmacology
Radioactive Tracers
Radioisotopes
/ chemistry
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
/ antagonists & inhibitors
Tissue Distribution
Zirconium
/ chemistry
CSF1R inhibitor
HDL
PET/CT imaging
immunotherapy
tumor-associated macrophages
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
01
05
2019
accepted:
24
07
2019
pubmed:
20
8
2019
medline:
29
9
2020
entrez:
18
8
2019
Statut:
ppublish
Résumé
The immune function within the tumor microenvironment has become a prominent therapeutic target, with tumor-associated macrophages (TAMs) playing a critical role in immune suppression. We propose an
Identifiants
pubmed: 31420495
pii: jnumed.119.230466
doi: 10.2967/jnumed.119.230466
pmc: PMC7067531
doi:
Substances chimiques
Aminopyridines
0
Csf1r protein, mouse
0
Lipoproteins, HDL
0
Pyrroles
0
Radioactive Tracers
0
Radioisotopes
0
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
0
pexidartinib
6783M2LV5X
Zirconium
C6V6S92N3C
Zirconium-89
NTM296JU95
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
433-436Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA220234
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA232130
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA204441
Pays : United States
Organisme : NIBIB NIH HHS
ID : F32 EB025050
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.
Références
Oncotarget. 2017 May 2;8(18):30576-30586
pubmed: 28427165
Lancet Oncol. 2011 Sep;12(9):913-22
pubmed: 21349766
J Immunother Cancer. 2017 Jul 18;5(1):53
pubmed: 28716061
Cold Spring Harb Perspect Biol. 2014 Jun 02;6(6):
pubmed: 24890514
Eur J Cancer. 2018 Jan;88:38-47
pubmed: 29182990
Annu Rev Physiol. 2017 Feb 10;79:541-566
pubmed: 27813830
Cancer Discov. 2011 Jun;1(1):54-67
pubmed: 22039576
Oncoimmunology. 2013 Dec 1;2(12):e26968
pubmed: 24498562
Science. 2004 Nov 5;306(5698):966-8
pubmed: 15528423
Adv Drug Deliv Rev. 2010 Mar 8;62(3):329-38
pubmed: 19900496
NMR Biomed. 2006 Feb;19(1):142-64
pubmed: 16450332
Cancer. 2018 Sep 1;124(17):3500-3509
pubmed: 30189117
Semin Cancer Biol. 2015 Dec;35:85-95
pubmed: 26319607
J Nucl Med. 2015 Aug;56(8):1272-7
pubmed: 26112022
Nat Rev Cancer. 2019 Mar;19(3):133-150
pubmed: 30755690
J Clin Oncol. 2018 Mar 20;36(9):850-858
pubmed: 29341833
Cancers (Basel). 2014 Aug 13;6(3):1670-90
pubmed: 25125485
JACC Cardiovasc Imaging. 2016 Aug;9(8):950-61
pubmed: 27236528
NPJ Breast Cancer. 2016;2:
pubmed: 26998515
Eur J Cancer. 2016 Jul;62:132-7
pubmed: 27189322
J Clin Oncol. 2016 May 1;34(13):1510-7
pubmed: 26951310
J Biol Chem. 2002 May 31;277(22):20026-32
pubmed: 11916959
Nat Rev Cancer. 2006 Jan;6(1):24-37
pubmed: 16397525
Mol Cell Biol. 1992 Mar;12(3):954-61
pubmed: 1312220
Nat Mater. 2014 Feb;13(2):125-38
pubmed: 24452356